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A monodisperse truncation mutant of MxiH, the subunit of the needle from the
Shigella ﬂexneri type III secretion system (TTSS), has been overexpressed and
puriﬁed. Crystals were grown of native and selenomethionine-labelled MxiHC5
and diffraction data were collected to 1.9 A ˚ resolution. The crystals belong to
space group C2,withunit-cell parameters a=183.4,b=28.1,c=27.8 A ˚ , =96.5 .
An anomalous difference Patterson map calculated with the data from the
SeMet-labelled crystals revealed a single peak on the Harker section v =0 .
Inspection of a uranyl derivative also revealed one peak in the isomorphous
difference Patterson map on the Harker section v = 0. Analysis of the self-
rotation function indicates the presence of a twofold non-crystallographic
symmetry axis approximately along a. The calculated Matthews coefﬁcient is
1.9 A ˚ 3 Da
 1 for two molecules per asymmetric unit, corresponding to a solvent
content of 33%.
1. Introduction
Type III secretion systems (TTSSs) are essential virulence determi-
nants in many Gram-negative bacterial pathogens. The TTSS is
required to translocate virulence effectors into the host cell. The
TTSS consists of a ‘needle complex’ composed of an external hollow
needle held within a basal body that traverses both bacterial
membranes. Secretion is activated by contact of the tip of the needle
complex with host cells, resulting in the formation of a pore in the
host-cell membrane that is contiguous with the needle. Other effector
proteins are injected via this apparatus directly into the host-cell
cytoplasm (for a review, see Johnson et al., 2005).
Many of the 25 Shigella proteins from which the TTSS is
constructed are similar either in sequence or function to cytoplasmic
and inner membrane (IM) proteins of bacterial ﬂagellar hook-basal
bodies (Blocker et al., 2003). The ﬂagellum is a helical superstructure
that is assembled by the export of the ﬂagellar components (ﬂagellin
and FlgE) through a central channel of the ﬂagellum in a process
highly analogous to the initial steps of export through a virulence
TTSS (Mimori et al., 1995; Yonekura et al., 2003). The Shigella ﬂexneri
needle is composed of the  9 kDa protein MxiH that assembles in a
helical superstructure architecturally similar to the ﬂagellar hook and
ﬁlament (Cordes et al., 2003; Samatey, Matsunami, Imada, Naga-
shima, Shaikh et al., 2004; Yonekura et al., 2003). A model of the
innermost (D0) domain of ﬂagellin built in a high-resolution EM map
forms a tube  70 A ˚ in diameter with a central channel of  20 A ˚ ,
similar to the dimensions described for the S. ﬂexneri needle
(Yonekura et al., 2003; Cordes et al., 2003). Despite their different
sizes and lack of sequence homology, these proteins may be struc-
turally similar in the regions used to pack into superhelices. MxiH
may thus represent the minimum core required to build a helical
assembly suitable for host-cell sensing and protein export.
In Shigella, full-length MxiH is expressed and, following export,
polymerizes to form TTSS needles (Cordes et al., 2003). The needles
themselves are too large and too heterogeneous in length to be
amenable to crystallization. Attempts to obtain monomeric MxiH
protein directly by depolymerization of the ﬁlaments and partial
proteolysis were not successful. The segments of the ﬂagellar hook
and ﬁlament proteins that pack into the innermost region of the
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All rights reservedﬂagellar ﬁlament were proteolytically removed (the N-terminal 70
and C-terminal 44 residues of FlgE and the N-terminal 52 and
C-terminal 44 residues of ﬂagellin) in order to produce monomeric
crystallizable forms of these subunits (Samatey et al., 2000; Samatey,
Matsunami, Imada, Nagashima & Namba, 2004). Here, largely owing
to the small size of MxiH (9 kDa), prevention of polymerization was
achieved by the removal of ﬁve C-terminal residues (MxiHC5;
Kenjale et al., 2005).
2. Experimental procedures
2.1. Expression and purification
Recombinant forms of MxiHC5 were produced and puriﬁed. The
DNA fragment of the mxiH gene encoding residues 1–78 was
produced as described previously (Kenjale et al., 2005) and subcloned
into the pET22b vector. This construct includes two additional resi-
dues (Leu79 and Glu80) that link the truncated form of MxiH to a
C-terminal His6 tag.
MxiHC5 was expressed in Escherichia coli BL21 (DE3) cells
grown in LB media containing 100 mgm l
 1 ampicillin. Cells were
grown at 310 K until an A280nm of  0.6 was reached, whereupon the
solutions were cooled to 293 K and protein overexpression was
induced by the addition of 1.0 mM IPTG. After  16 h, cells were
harvested by centrifugation (15 min, 5000g, 277 K) and pellets were
frozen at 193 K. Cell pellets were resuspended in lysis buffer (20 mM
Tris pH 7.5, 150 mM NaCl and Complete EDTA-free protease inhi-
bitor cocktail, Roche) and lysed using an Emulsiﬂex-C5 Homogeniser
(Glen Creston, UK). The resultant cell suspension was centrifuged
(20 min, 20 000g, 277 K) and the soluble fraction was applied to a pre-
charged HiTrap HP nickel-afﬁnity column (HiTrap Chelating HP,
Amersham Biosciences). Protein was eluted using a gradient of
0–1 M imidazole in 20 mM Tris pH 7.5 and 150 mM NaCl. Fractions
containing MxiHC5 were further puriﬁed by gel-ﬁltration chroma-
tography using a HiLoad 16/60 Superdex 75 column (Amersham
Biosciences). MxiHC5 elutes in 20 mM Tris pH 7.5, 150 mM NaCl as
a single slightly asymmetric peak. SDS–PAGE analysis revealed
MxiHC5 to be pure and mass-spectrometric analysis (data not
shown) conﬁrmed the molecular weight of the protein (9540   1 Da).
Fractions containing puriﬁed MxiHC5 were pooled and concentrated
using Centricon YM-3 centrifugal ﬁltration devices (Millipore) to
approximately 25 mg ml
 1 and were stored at 193 K.
The sequence of MxiH contains no methionine residues that could
be exploited for preparation of selenomethionine derivatives and no
cysteine residues that could be used for anomalous phasing based on
sulfur. On the basis of a sequence alignment that identiﬁed a
conserved hydrophobic residue at position 19 that is a methionine in
the enteropathic E. coli (EPEC) homologue, EscF, a methionine-
containing point mutant of MxiHC5 was generated (MxiHC5F19M).
This F19M MxiH mutant in the context of wild-type Shigella
assembled phenotypically normal needles (data not shown). SeMet-
labelled MxiHC5F19M was produced by expression in the E. coli met
 
auxotrophic strain B834 (DE3). Cultures were grown in LB media to
an A600nm of 0.9, were pelleted (15 min, 4000g, 277 K) and washed in
PBS three times before being used to inoculate SelenoMet Medium
Base containing SelenoMet Nutrient Mix (Molecular Dimensions,
UK). Cells were grown and induced as described above. SeMet-
labelled protein was puriﬁed as described above. Full incorporation
of selenomethionine was conﬁrmed by mass spectrometry (data not
shown).
2.2. Crystallization
Initial crystallization conditions were obtained by sparse-matrix
screening (Jancarik & Kim, 1991) using the sitting-drop vapour-
diffusion technique. Drops were prepared by mixing 0.2 ml protein
solution (25 mg ml
 1,2 0m M Tris pH 7.5, 150 mM NaCl) with 0.2 ml
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Figure 1
Monoclinic crystals of MxiHC5. Native crystals had a longest dimension of
approximately 25 mm.
Table 1
Data-collection statistics.
Values for the highest resolution shell are given in parentheses.
Native
Uranyl [UO2(AcO2)2]
soak
SeMet MAD
Peak ( 1) Remote ( 2) Inﬂection ( 3)
X-ray source ESRF, ID14-4 ESRF, ID14-2 ESRF, ID23
Detector ADSC scanner ADSC scanner MAR CCD
Space group C2 C2 C2
Unit-cell parameters
a (A ˚ ) 183.2 182.8 183.4
b (A ˚ ) 28.1 28..0 28.1
c (A ˚ ) 27.7 27.5 27.8
  ( ) 96.5 96.0 96.5
Wavelength (A ˚ ) 0.976 0.9330 0.9794 0.9757 0.9797
Resolution limit (A ˚ ) 28–2.1 (2.2–2.1) 26–3.2 (3.5–3.2) 28–1.9 (2.0–1.9) 28–2.3 (2.4–2.3) 28–2.3 (2.4–2.3)
Completeness (%) 99.9 (99.9) 99.7 (99.7) 99.7 (99.4) 99.4 (99.0) 99.7 (99.1)
Unique reﬂections 8232 1815 11111 6408 6405
Multiplicity 4.3 (4.4) 3.1 (3.1) 4.7 (4.8) 6.7 (7.1) 6.7 (10.4)
Rmerge† 6.6 (25.1) 14.6 (34.3) 5.4 (21.7) 10.3 (29.8) 7.8 (22.9)
I/ (I) 7.7 (2.9) 2.4 (1.7) 5.6 (2.7) 4.0 (1.0) 5.5 (2.9)
Ranom‡ 7.7 (15.9) 3.4 (15.4) 4.7 (10.0) 3.4 (8.5)
† Rmerge = 100
P
h½
P
i jhIðhÞi   IðhÞij=
P
i IðhÞi , where I(h)i is the ith observation of reﬂection h and hI(h)i is the mean intensity of all observations of h.‡ Ranom =
100
P
h jhIþi h I ij=
P
hðhIþiþh I iÞ, where hI
+i and hI
 i are the mean intensities of the Bijvoet pairs for observation h.reservoir solution and were equilibrated against 100 ml reservoir
solution at 293 K. Crystals of MxiHC5 grew overnight in condition
No. 9 of Molecular Dimensions Screen 1 [20%(w/v) PEG 4000, 0.1 M
sodium citrate pH 5.6, 20%(v/v) 2-propanol]. Crystals grown exactly
as above but with the addition of 12%(v/v) glycerol to the mother
liquor yielded diffraction-quality crystals of MxiHC5 (Fig. 1). Crys-
tals of SeMet-labelled MxiHC5F19M were grown as described above,
except that drops were prepared by mixing 1.0 ml protein solution
with 1.0 ml reservoir solution and were equilibrated against 0.5 ml
reservoir solution. Diffraction-quality crystals grew in 3 days in
condition No. 9 of Molecular Dimensions Screen 1 supplemented
with 2%(w/v) xylitol. Uranyl derivatives were prepared by transfer-
ring MxiHC5 crystals into a drop containing reservoir solution
saturated with uranyl acetate. Crystals were soaked overnight at
293 K.
2.3. Data collection and processing
Crystals of MxiHC5 were mounted and ﬂash-cooled directly in the
cryostream. Crystals of MxiHC5F19M and the uranyl derivative were
cryoprotected in reservoir solution containing 15%(v/v) ethylene
glycol for 15 s and ﬂash-cooled in liquid nitrogen for data collection.
Diffraction data were recorded at 100 K (Table 1). Data were
indexed and integrated in MOSFLM (Leslie, 1992) and scaled with
SCALA (Evans, 1997) within the CCP4 program suite (Collaborative
Computational Project, Number 4, 1994). Isomorphous (uranyl) and
anomalous (SeMet) difference Patterson maps calculated within
autoSHARP (Vonrhein et al., 2005) using (E
2   1) coefﬁcients and
strict outlier rejection clearly demonstrated the presence of a single
site in both derivatives when calculated at a variety of resolution
limits (Fig. 2). Inspection of isomorphous difference Patterson maps
using the SeMet data (either between data collected at different
wavelengths or compared with the native data) did not provide
supporting evidence for an ordered Se within the crystals.
3. Results and discussion
Rod-shaped crystals of MxiH belong to the monoclinic space group
C2. The value of the Matthews coefﬁcient is 1.9 A ˚ 3 Da
 1 for two
molecules per asymmetric unit, corresponding to a solvent content of
33% (one molecule would correspond to 66% solvent content;
Matthews, 1968). The self-rotation function for the SeMet peak data
set (Fig. 3) indicates the presence of a twofold non-crystallographic
symmetry axis almost parallel to a that is consistent with two mole-
cules of MxiHC5 per asymmetric unit but inconsistent with the
observation of only a single peak in the SeMet anomalous Patterson
maps. Absolute determination of the asymmetric unit contents awaits
structure determination.
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Figure 2
Difference Patterson maps of MxiHC5.( a) Anomalous difference Patterson map
calculated at 3.2 A ˚ resolution with data collected at   = 0.9794 A ˚ (Table 1). (b)
Isomorphous difference Patterson map for the uranyl derivative calculated at 4.3 A ˚
resolution with data collected at   = 0.9330 A ˚ (Table 1). The asymmetric unit of the
Harker section (v = 0) is shown. Maps are drawn with a minimum contour level of
1.5  with 0.3  increments.
Figure 3
The   = 180  section of the self-rotation function calculated for the SeMet peak
data set using POLARRFN (Collaborative Computational Project, Number 4,
1994) with an integration radius of 20 A ˚ and data in the resolution range 20–5 A ˚ .
The peak (marked with an X) at (’,  ) = (70.8, 0 ) represents 56.5% of the peak for
the crystallographic twofold.References
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